Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 9Dermatologic 5Thoracic 3Other 2Lymphoid 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Breast Neoplasms 13110Triple Negative Breast Neoplasms 1145Neoplasms 748Ovarian Neoplasms 676Neoplasm Metastasis 588Lung Neoplasms 581Colorectal Neoplasms 576Prostatic Neoplasms 559Carcinoma, Non-Small-Cell Lung 533Pancreatic Neoplasms 380Melanoma 366Stomach Neoplasms 349Colonic Neoplasms 330Motor Activity 285Breast Neoplasms, Male 285Carcinoma, Intraductal, Noninfiltrating 277Uterine Cervical Neoplasms 265Head and Neck Neoplasms 265Endometrial Neoplasms 254Carcinoma, Renal Cell 215Sarcoma 202Urinary Bladder Neoplasms 192Squamous Cell Carcinoma of Head and Neck 190Lymphedema 190Breast Carcinoma In Situ 189Esophageal Neoplasms 188Brain Neoplasms 183Fatigue 166Carcinoma, Ovarian Epithelial 151Breast Cancer Female 148

Interventions

Loperamide 1Fecal Microbiota Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colitis × Breast × Clear all
NCT04038619 2026-03-20

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

M.D. Anderson Cancer Center

Phase 1 Recruiting
40 enrolled
BreastDermatologicGynecologicThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Colitis, Diarrhea, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Urogenital Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡